Amneal Pharmaceuticals, Inc. logo AMRX - Amneal Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 6
SELL 0
STRONG
SELL 0
| PRICE TARGET: $17.33 DETAILS
HIGH: $19.00
LOW: $16.00
MEDIAN: $17.00
CONSENSUS: $17.33
UPSIDE: 39.53%

Profitability Ratios

Ratio Value
GP Margin 37.6%
EBIT Margin 12.6%
EBITDA Margin 20.0%
Operating Margin 14.0%
Pretax Margin 4.6%
Cont. Ops Margin 4.2%
Net Margin 2.4%
Bottom Line Margin 2.4%

Liquidity Ratios

Ratio Value
Current Ratio 2.17
Quick Ratio 1.48
Solvency Ratio 0.081
Cash Ratio 0.35

Valuation Ratios

Ratio Value
Price/Earnings
54.80
Hist. avg: 33.5
Peers avg: 21.9
PEG Ratio -0.34
Forward PEG -0.34
Price/Book -55.77
Price/Sales 1.31
Price/FCF 14.63
Price/Op Cash Flow 11.61

Debt Ratios

Ratio Value
Debt/Assets 0.7440
Debt/Equity -38.6540
Debt/Capital 1.0266
Long-Term Debt/Capital 1.0279
Financial Leverage -51.96

Cash Flow Ratios

Ratio Value
Working Capital Turnover 4.06
Operating Cash Flow Ratio 0.386
Operating Cash Flow/Sales 11.3%
Free Cash Flow/Operating Cash Flow 79.4%

Coverage Ratios

Ratio Value
Debt Service Coverage 2.26
Interest Coverage 1.7549
Short-Term Operating Cash Flow Coverage 15.76
Operating Cash Flow Coverage 0.12
Capital Expenditure Coverage 4.85
Dividend + Capital Expenditure Coverage 4.85

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 9.63
EPS 0.230
Debt/Share 9.5018
Cash/Share 0.99
Book Value/Share 0.02
Tangible BV/Share -3.68
Equity/Share -0.23
Operating Cash Flow/Share 1.085
Capital Expenditure/Share 0.224
FCF/Share 0.861

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.518
Earnings Before Tax/EBIT 0.329
Price/Fair Value -55.77
Debt/Market Cap 0.6671
Effective Tax Rate 8.1%
Enterprise Value Multiple 10.56